Sat-13-02-2016, 12:35 PM
(Sat-13-02-2016, 04:46 AM)Quest4Cure Wrote:(Fri-12-02-2016, 13:35 PM)Fred Wrote: I doubt very much that Europe will be using it as a First Line. Most of Europe follow the same protocol. And Bio's are last on the list.
It's what I read in the reports on the drug. Check for urself online... What I just pulled this info out of my hat?
Hello Quest I'm sorry but I think we are misunderstanding each other (it's a hobby of mine)
I have read the reports, we have them here: Cosentyx approved for treating psoriasis in Europe
But what I was referring to in my comment is that a Bio will not be given as a First Line treatment. The protocol dictates #1 Creams #2 Light #3 Oral #4 Bio. So what I'm saying is it will never be given first.
I think the reference in the official statement Cosentyx approved for treating psoriasis in Europe means it can be offered as a first line when moving on to bio's instead of trying Remicade, Enbrel, Humira, Stelara first.
I hope that explains what I was meaning and I certainly do not think you "Pull things out of your hat" and I was not insinuating that you do.